Exchange: NASDAQ·Updated 03:28 PM EDT
EXEL logo

EXEL Exelixis Inc

$60.89
$1.38
(2.32%)
Today
EarningsOct 27
Mkt Cap$14.75B
Vol1.31M

About EXEL

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
70

Bullish Sentiment

How do you feel about EXEL?

Johnnyf22
$EXEL big time rug pull underway. Big boys ran it up till noon today to unload shares. Big sell off. Not sure if news just hit or or whether it’s just algos. Hard for breakouts to work however with the changing policies minute by minute by this admin every day. Hopefully this admin will stop being so volatile so the stock market can stop being so volatile. They go hand in hand.

Advertisement|Remove ads.